Franz-Josef Meyer-Almes
Hochschule Darmstadt
H-index: 24
Europe-Germany
Top articles of Franz-Josef Meyer-Almes
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Design and synthesis of peptides as stabilizers of histone deacetylase 4 | Journal of Peptide Science | Annika Lill Markus Schweipert Thomas Nehls Eva Wurster Frederik Lermyte | 2024/4/16 |
Diaryl Pyrazoline, 1, 3, 4-Oxadizole, and 1, 2, 4-Triazole Pharmacophore Hybridization: Design, Synthesis, HDAC Inhibition, and Caspase 3/7 Activation Studies | Russian Journal of Bioorganic Chemistry | Abdullah Yahya Abdullah Alzahrani Pratibha Gupta Vijay Patil Franz-Josef Meyer-Almes DV Sokolova | 2024/4 |
The catalytic domain of free or ligand bound histone deacetylase 4 occurs in solution predominantly in closed conformation | Protein Science | Markus Schweipert Thomas Nehls Anton Frühauf Cecilé Debarnot Adarsh Kumar | 2024/3 |
Selective HDAC8 inhibitors and their uses | 2023/10/31 | ||
Significance of five-membered heterocycles in human histone deacetylase inhibitors | Anton Frühauf Martin Behringer Franz-Josef Meyer-Almes | 2023/7/27 | |
Design, Synthesis, and Biological Evaluation of Novel Quinazolin-4 (3H)-One-Based Histone Deacetylase 6 (HDAC6) Inhibitors for Anticancer Activity | Future Journal of Pharmaceutical Sciences | Iten M Fawzy Khairia M Youssef Nasser SM Ismail Joachim Gullbo Khaled AM Abouzid | 2015/6/1 |
Design, synthesis, and biological evaluation of tetrahydroisoquinoline based hydroxamate derivatives as HDAC 6 inhibitors for cancer therapy | Journal of Molecular Structure | Yogesh Mahadu Khetmalis Bakhya Shree Boddupalli Venkata Siva Kumar Markus Schweipert Cécile Debarnot | 2023/4/15 |
Continuous enzyme activity assay for high-throughput classification of histone deacetylase 8 inhibitors | Exploration of Targeted Anti-tumor Therapy | Markus Schweipert Anuja Amurthavasan Franz-Josef Meyer-Almes | 2023 |
Electrophilic MiniFrags Revealed Unprecedented Binding Sites for Covalent HDAC8 Inhibitors | Journal of Medicinal Chemistry | Aaron B Keeley Aleksandra Kopranovic Vincenzo Di Lorenzo Péter Ábrányi-Balogh Niklas Jänsch | 2023/12/19 |
3‐Chloro‐5‐Substituted‐1, 2, 4‐Thiadiazoles (TDZs) as Selective and Efficient Protein Thiol Modifiers | ChemBioChem | Niklas Jänsch Anton Frühauf Markus Schweipert Cécile Debarnot Miriam Erhardt | 2022/11/4 |
Synthesis and Characterization of Reversible Covalent HDAC4 Inhibitors | Anton Frühauf Benjamin Wolff Markus Schweipert Franz-Josef Meyer-Almes | 2022/10/19 | |
Methionine 274 is not the determining factor for selective inhibition of histone deacetylase 8 (HDAC8) by L-shaped inhibitors | International Journal of Molecular Sciences | Niklas Jänsch Kim Leoni Lang Franz-Josef Meyer-Almes | 2022/10/4 |
Synthesis and HDAC inhibitory activity of pyrimidine-based hydroxamic acids | Beilstein journal of organic chemistry | Virginija Jakubkiene Gabrielius Ernis Valiulis Markus Schweipert Asta Zubriene Daumantas Matulis | 2022/7/13 |
Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription | Nucleic acids research | Martina Minisini Eros Di Giorgio Emanuela Kerschbamer Emiliano Dalla Massimo Faggiani | 2022/3/21 |
Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks | RSC Medicinal Chemistry | Neha Upadhyay Kalpana Tilekar Sabreena Safuan Alan P Kumar Markus Schweipert | 2021 |
HDAC4 Inhibitors with Cyclic Linker and Non‐hydroxamate Zinc Binding Group: Design, Synthesis, HDAC Screening and in vitro Cytotoxicity evaluation. | ChemistrySelect | Kalpana Tilekar Jessica D Hess Neha Upadhyay Markus Schweipert Felix Flath | 2021/7/13 |
Development and investigation of thiazolidinedione and pyrazoline compounds as antiangiogenic weapons targeting VEGFR-2 | Future medicinal chemistry | Neha Upadhyay Kalpana Tilekar Sabreena Safuan Alan P Kumar Markus Schweipert | 2021/11 |
Thiazolidinedione “Magic Bullets” Simultaneously Targeting PPARγ and HDACs: Design, Synthesis, and Investigations of their In Vitro and In Vivo Antitumor Effects | Journal of Medicinal Chemistry | Kalpana Tilekar Jessica D Hess Neha Upadhyay Alessandra Lo Bianco Markus Schweipert | 2021/5/18 |
Double-edged swords: diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesis | Bioorganic chemistry | Neha Upadhyay Kalpana Tilekar Sabreena Safuan Alan P Kumar Markus Schweipert | 2021/11/1 |
Discovery of dihydro-1, 4-benzoxazine carboxamides as potent and highly selective inhibitors of sirtuin-1 | Journal of Medicinal Chemistry | Martin Spinck Matthias Bischoff Philipp Lampe Franz-Josef Meyer-Almes Sonja Sievers | 2021/4/20 |
Co-Authors
